Drug-eluting stents in the below-knee circulation for patients with critical limb ischemia: when and where
Thomas J Ward1, Robert A Lookstein1
1Department of Interventional Radiology, One Gustave L Levy Place Box 1234, Mount Sinai Medical Center, New York, NY.
Insights
Critical limb ischemia (CLI) management is evolving. Drug-eluting stents (DESs) show promise for below-knee circulation, offering improved outcomes compared to traditional treatments for infrapopliteal disease.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Artery Disease
Background:
- Critical limb ischemia (CLI) significantly impairs mobility and quality of life, often leading to limb loss.
- Managing below-knee circulation disease presents technical challenges like long occlusions and calcifications.
- Treatment options have advanced beyond balloon angioplasty to include various stenting and atherectomy devices.
Purpose of the Study:
- To review recent evidence supporting the expanded use of drug-eluting stents (DESs) in critical limb ischemia.
- To focus on advances in treating infrapopliteal disease within the context of CLI.
- To discuss the application of DESs in both routine and complex clinical scenarios for CLI patients.
Main Methods:
- Review of prospective randomized studies comparing DESs with bare-metal stents and balloon angioplasty.
- Analysis of recent evidence-based advances in infrapopliteal revascularization for CLI.
- Discussion of clinical experiences with DESs in managing CLI below the knee.
Main Results:
- Drug-eluting stents (DESs) demonstrate promising results in infrapopliteal vessels for CLI patients.
- Recent studies indicate favorable outcomes for DESs compared to older treatment modalities.
- Technological advancements and operator experience are improving the management of complex lesions.
Conclusions:
- Evidence supports a broader application of DESs for critical limb ischemia with infrapopliteal disease.
- DESs represent a significant advancement in treating challenging below-knee circulation issues.
- Further evaluation of DESs in routine and complex CLI cases is warranted.
Abstract:
Critical limb ischemia (CLI) is a challenging disease that carries a grim prognosis; limb loss is a frequent occurrence that drastically affects patient mobility and quality of life. The management of this disease in the below-knee circulation is changing rapidly. The frequently encountered technical challenges, long lesions, total occlusions, dense calcifications, are being overcome by increased operator experience and improved technology. A decade ago, balloon angioplasty was the mainstay of treatment, currently, bare-metal stents, drug-eluting stents (DESs), atherectomy devices, and cryoplasty have been explored with varying degrees of success. Over the past few years, DESs in the infrapopliteal vessels have shown promising results. Several prospective randomized studies have been completed, which compare the use of DESs with bare-metal stents or balloon angioplasty for CLI with infrapopliteal disease. This article focuses on the recent evidence-based advances supporting a wider use of DESs in patients with CLI and infrapopliteal disease. The use of DESs in routine and challenging clinical scenarios is also discussed.
More Related Videos
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome I: Introduction


